# Objective Confirmation of thе Anti-ischemic Effectiveness of Trimetazidine 80mg Once Daily in Patients With Stable Angina Who Had a History of Myocardial Infarction (METHOD)

> **NCT05210465** · — · COMPLETED · sponsor: **Servier Russia** · enrollment: 36 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **OTHER:** speckle tracking mode of the stress ECHO test with dobutamine

## Key facts

- **NCT ID:** NCT05210465
- **Lead sponsor:** Servier Russia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-03
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-04-17
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05210465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05210465, "Objective Confirmation of thе Anti-ischemic Effectiveness of Trimetazidine 80mg Once Daily in Patients With Stable Angina Who Had a History of Myocardial Infarction (METHOD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05210465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*